SPRITZE

European patent · EP3858405 · In force

Register entry

Publication number
EP3858405
Application number
EP21164847
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 30, 2013
Published
Aug 4, 2021
Granted
Apr 5, 2023
Protection ends at the latest
May 29, 2033
Next annual fee due
May 31, 2027
IPC classes
A61M 5/315 (2006.01)
A61M 5/28 (2006.01)
A61M 5/31 (2006.01)
Priority
EP 12170628 01.06.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. May 21, 2025

    Change

    Published in Swissreg on 21.05.2025

  4. Mar 19, 2025

    Change

    Published in Swissreg on 19.03.2025

  5. Feb 12, 2025

    Change

    Published in Swissreg on 12.02.2025

  6. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  7. Mar 13, 2024

    Change

    Published in Swissreg on 13.03.2024

  8. Jan 17, 2024

    Change

    Published in Swissreg on 17.01.2024

3 earlier entries
  1. Jul 12, 2023

    Change

    Published in Swissreg on 12.07.2023

  2. Jun 2, 2023

    Change

    Published in Swissreg on 02.06.2023

  3. Apr 5, 2023

    Granted

    Published in Swissreg on 05.04.2023

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

PAPST, Wolfgang

4002 Basel

PICCI, Marie

4002 Basel

BUETTGEN, Heinrich

4002 Basel

BRYANT, Andrew

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.